The current chairman of the Novo Nordisk Foundation, Lars Rebien Sorensen, who served as the pharma's chief executive from ...

The Novo Nordisk Foundation owns 28.1% of the company's shares, but holds a three-quarter share of the voting rights, which ...

With promising new obesity treatments in the pipeline, 24/7 Wall St. projects huge upside for Novo Nordisk stock through 2030 ...

After clearing Novo Nordisk’s semaglutide treatments Ozempic and Wegovy to reduce the risk of major adverse cardiovascular ...

Denmark's Novo Nordisk said Tuesday it would replace more than half of its board, including the chair, as the Ozempic and ...

The Ozempic maker’s controlling shareholder intends to replace seven directors, including the Denmark-based company’s ...

Novo Nordisk A/S Chairman Helge Lund is stepping down after a boardroom dispute over governance and will be replaced by Lars Rebien Sorensen, a previous leader of the company who now heads its biggest ...

An April 2025 report from the Initiative for Medicines, Access & Knowledge (I-MAK) presents grossly misleading information ...

Michigan lawmakers plan to save money in the state's Medicaid program by limiting the use of popular weight loss drugs to ...

A new interactive budget tool from Levity helps users see whether GLP-1 medications fit into their real-world finances.

Pfizer ( PFE) is number one and the leader in my list of "top 3 Big Pharma stocks." Over the last three quarters I have seen ...